Interim Analyses During Group Sequential Trials With Dr Meurer
William J. Meurer, MD, MS, University of Michigan Medical School, discusses Interim Analyses During Group Sequential Trials with JAMA Statistical Editor Roger J. Lewis, MD, PhD.
William J. Meurer, MD, MS, University of Michigan Medical School, discusses Interim Analyses During Group Sequential Trials with JAMA Statistical Editor Roger J. Lewis, MD, PhD.
Interview with Barry A. Borlaug, MD, and Jwan A. Naser, MBBS, authors of Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation. Hosted by James…
Nanopore DNA screening technology may identify novel pathogens, propose treatments in as little as six hours
We’re entering an era of autonomous agents capable of executing complex, multistep workflows
States, cities and counties have big opportunities to use artificial intelligence to improve response time.
Online shopping for Kindle Store from a great selection of Specialties, Internal Medicine, Basic Science, Administration & Policy, Alternative & Holistic, Nursing & more at…
RFK Jr. may push the FDA to gather more data, and could try to fill the CDC’s Advisory Committee on Immunization Practices with vaccine skeptics.
Medical AI assistant Suki will help keep track of what happens at your online appointment
Objectives (1) To examine if a more accessible built environment (BE) is significantly associated with better knee function outcomes in knee osteoarthritis (OA) patients. (2)…
Medicine and Science from The BMJ · Episode
After TSMC announced plans for a US fab producing advanced sub-5nm chips, a milestone tool-in ceremony was held in December 2022 to celebrate the arrival…